Read Books Online and Download eBooks, EPub, PDF, Mobi, Kindle, Text Full Free.
Effect Of Patient Decision Aids On Changes In Mens Prostate Cancer Screening Behavior A Systematic Review And Meta Analysis
Download Effect Of Patient Decision Aids On Changes In Mens Prostate Cancer Screening Behavior A Systematic Review And Meta Analysis full books in PDF, epub, and Kindle. Read online Effect Of Patient Decision Aids On Changes In Mens Prostate Cancer Screening Behavior A Systematic Review And Meta Analysis ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
Book Synopsis Effect of Patient Decision Aids on Changes in Men's Prostate Cancer Screening Behavior : a Systematic Review and Meta-analysis by : Ilya Ivlev
Download or read book Effect of Patient Decision Aids on Changes in Men's Prostate Cancer Screening Behavior : a Systematic Review and Meta-analysis written by Ilya Ivlev and published by . This book was released on 2017 with total page 112 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Book Synopsis The Effects of Shared Decision Making on Cancer Screening by : Sarah E. Lillie
Download or read book The Effects of Shared Decision Making on Cancer Screening written by Sarah E. Lillie and published by . This book was released on 2014 with total page 114 pages. Available in PDF, EPUB and Kindle. Book excerpt: Decisions about cancer screening have become increasingly complex. Patients must decide whether to get screened, which screening modality to use, and how often to undergo and when to stop screening. Some cancer screening decisions are considered "preference-sensitive," meaning that, due to closely-balanced benefits and harms, the "right" decision is in part dependent on an individual's values and preferences for particular outcomes. Most organizations publishing clinical practice guidelines for cancer screening now recommend that preference-sensitive cancer screening decisions be made individually, using a process that considers the available evidence on the benefits and harms of particular options, and incorporates patient values and preferences relevant to those options. This approach is sometimes referred to as shared decision making (SDM). The goal of SDM interventions is to facilitate this approach. Adjuncts for the usual counseling for specific decisions, SDM interventions may include: (1) tools to help patients comprehend information about the risks and benefits of options, clarify their personal values related to these options, and participate in decisions consistent with these values and preferences (sometimes referred to as "decision aids") and (2) other interventions to prepare health care providers and/or systems to support this process. SDM interventions differ from many health-related interventions in that they primarily seek to elicit and support patient values and preferences in making health care-related decisions rather than to promote a particular health care strategy per se. In this review we examine the effects of SDM interventions for cancer screening in adults on constructs from the Ottawa Decision Support Framework, a commonly-used theoretical model of decision making. We examined the constructs of Decision Quality, Decision Impact, and, for studies reporting those outcomes, Decision Action. Decision Quality includes knowledge, values clarity (patients' clarity of their personal values regarding the risks and benefits of decision options), and the patients' participatory role in decision making. Decision Impact includes decisional conflict (personal uncertainty about which course of action to take), use of services (eg, consultation length), and satisfaction with the decision. Decision Action includes screening intention and behavior. The ideal SDM intervention would enhance Decision Quality (ie, increase knowledge and values clarity) and Impact (ie, increase satisfaction, reduce decision conflict, and have minimal impact on service utilization). The desired impact on Decision Action depends on the screening decision. For decisions about how to screen (such as colorectal cancer screening), the ideal SDM intervention would exert the desired effects on Decision Quality and Impact without reducing measures of Decision Action such as screening intention and behavior. For decisions about whether to screen (such as breast, cervical, and prostate cancer in some age groups and risk categories), the goal is to facilitate personalized decision making based on values and preferences. Hence, there are no desired effects on Decision Action per se in this context. We examine patient, provider, system, and multi-level SDM interventions, and therefore do not restrict this review to the most commonly employed SDM intervention of patient-directed decision aids. This topic was nominated by Linda Kinsinger, MD, MPH, VA Chief Consultant for Preventive Medicine at the VA National Center for Health Promotion and Disease Prevention (NCP). The evidence review is intended to examine the effects of SDM interventions for cancer screening practices and to inform what types of interventions NCP will disseminate with their cancer screening guidelines.
Book Synopsis A Randomized Controlled Trial Comparing Internet and Video to Facilitate Shared Decision-making for Men Considering the Prostate Specific Antigen Test by : Dominick Ludwig Frosch
Download or read book A Randomized Controlled Trial Comparing Internet and Video to Facilitate Shared Decision-making for Men Considering the Prostate Specific Antigen Test written by Dominick Ludwig Frosch and published by . This book was released on 2003 with total page 166 pages. Available in PDF, EPUB and Kindle. Book excerpt: BACKGROUND: Little is known about the relative advantages of video versus internet-based decision aids to facilitate shared medical decision making. This study compared internet and video patient education modalities for men considering the prostate specific antigen (PSA) test. METHODS: Two hundred and twenty-six men, aged 50 years or older, and scheduled to complete a physical examination at an HMO Health Appraisal Clinic were randomly assigned to access a website (N=114) or view a 23-minute videotape in the clinic (N=112) prior to deciding whether they wanted to be screened for prostate cancer. RESULTS: There were no between-groups differences in participants' ratings of convenience, effort, or satisfaction following exposure to the decision aid. Participants assigned to the video group were more likely to review the materials than individuals assigned to the internet group (98.2% vs 53.5%). Participants in the video group showed significantly greater increases in PSA knowledge and were more likely to decline the PSA test than individuals assigned to the internet group. However, participants in the internet group who reviewed the entire online presentation showed similar increases in PSA knowledge as video participants. Only 5% of all participants visited other websites to inform themselves about the PSA test. CONCLUSIONS: Overall, the video was significantly more effective than the Internet in educating participants about benefits and risks of PSA screening.
Book Synopsis An Exploration of Men's Decision Making and Decisional Conflict After Localised Prostate Cancer by : Suzanne Kathleen Steginga
Download or read book An Exploration of Men's Decision Making and Decisional Conflict After Localised Prostate Cancer written by Suzanne Kathleen Steginga and published by . This book was released on 2004 with total page pages. Available in PDF, EPUB and Kindle. Book excerpt: Abstract: The aim of this thesis is to describe how men with localised prostate cancer make decisions about their medical treatments, to describe the psychological and decision-related adjustment of these men over time, and to identify what variables predict decision-related adjustment. Chapter 1 reviews the medical context of localised prostate cancer and factors that influence men's decision making in this context. It is concluded that owing to ongoing uncertainty about the optimal medical treatment for this cancer and the substantial negative quality of life effects of treatments, how men make decisions in this context is an important research question. Further, although men with prostate cancer are high seekers of medical treatment information, knowledge about how men use such information and actually make this treatment decision is limited. -- Chapter 2 discusses research approaches currently applied to patient decision making: first, a social interaction approach encompassing the interaction between the patient and their physician and the social context influencing this interaction (Charles, Gafni, & Whelan, 1999); and second, normative decision theory (Shafir & Tversky, 1992; von Neumann & Morgenstern, 1947). The Heuristic-Systematic Processing model (Chaiken, 1980) is then proposed as a theoretical framework for investigating patient decision making that includes both systematic and non-systematic decision strategies. -- Chapter 3 reviews applied decision research in cancer, and presents an overview of research findings regarding patients' preferences for involvement in decision making, the relationship between decisional involvement and psychological adjustment, and decisional support interventions. Research on adjustment to cancer is discussed and the need for further research about men's psychological and decision-related adjustment after localised prostate cancer is identified. Finally, a multivariate analysis of decision-related adjustment for men with localised prostate cancer based on the stress and coping framework of Lazarus and Folkman (1984) is proposed. -- Chapter 4 describes Study 1 that was an experiment to investigate the utility of the Heuristic-Systematic Processing model (HSM) in explaining low desire for involvement in decision making about prostate cancer treatments as an example of use of the expert opinion heuristic. Using a hypothetical decision scenario about localised prostate cancer it was found that a low desire for involvement in decision making by men was predicted by a high belief in powerful others controlling health, a low belief in the self being responsible for good health, a high preference for black and white thinking, and a lower level of education. This study provides preliminary support for use of the HSM in this context and for the conceptualisation of decision deferral as the expert opinion heuristic. -- Chapter 5 introduces and describes the method of Study 2 that was a descriptive, prospective study of men's decision making after an actual diagnosis of localised prostate cancer. This method allowed for an analysis of men's decision making that includes both systematic and non-systematic processes, and for further investigation of the utility of the HSM in explaining decision behaviour. In addition, a multivariate approach was used to describe men's physical, psychological and decision-related adjustment over time, and to identify psychological predictors of decision-related adjustment. -- Chapter 6 describes men's use of systematic processing as limited and the use of non-systematic processes, such as lay beliefs and heuristics, as pervasive. It is concluded that patients do not utilise information about medical treatments in a comprehensive or systematic way when making treatment decisions and that patients' decision making is biased by their prior beliefs about cancer and health. A framework is outlined to demonstrate how the results of Study 1 and 2 support the application of the HSM to decision making about prostate cancer with particular reference to the role of beliefs about the physician, health locus of control, and uncertainty about the treatment decision in influencing decision strategies. -- Chapter 7 describes men's physical, psychological and decision-related adjustment over time, and concludes that decision-related distress is high but psychological distress in general is low. Decisional conflict at diagnosis and at twelve months concurrently, and at two months prospectively, was predicted by dispositional optimism; and this effect was mediated by the man's proximal cognitive appraisal of the impact of the cancer. It is concluded that decisional conflict is a person's cognitive judgment of the treatment decision that is generated by similar processes to that of the psychological distress that follows a cancer diagnosis. Conclusions and implications of these studies for future research in this area are summarised in Chapter 8.
Book Synopsis Doing Meta-Analysis with R by : Mathias Harrer
Download or read book Doing Meta-Analysis with R written by Mathias Harrer and published by CRC Press. This book was released on 2021-09-15 with total page 500 pages. Available in PDF, EPUB and Kindle. Book excerpt: Doing Meta-Analysis with R: A Hands-On Guide serves as an accessible introduction on how meta-analyses can be conducted in R. Essential steps for meta-analysis are covered, including calculation and pooling of outcome measures, forest plots, heterogeneity diagnostics, subgroup analyses, meta-regression, methods to control for publication bias, risk of bias assessments and plotting tools. Advanced but highly relevant topics such as network meta-analysis, multi-three-level meta-analyses, Bayesian meta-analysis approaches and SEM meta-analysis are also covered. A companion R package, dmetar, is introduced at the beginning of the guide. It contains data sets and several helper functions for the meta and metafor package used in the guide. The programming and statistical background covered in the book are kept at a non-expert level, making the book widely accessible. Features • Contains two introductory chapters on how to set up an R environment and do basic imports/manipulations of meta-analysis data, including exercises • Describes statistical concepts clearly and concisely before applying them in R • Includes step-by-step guidance through the coding required to perform meta-analyses, and a companion R package for the book
Book Synopsis Decision Aids for Cancer Screening and Treatment by : Thomas A. Trikalinos
Download or read book Decision Aids for Cancer Screening and Treatment written by Thomas A. Trikalinos and published by . This book was released on 2014 with total page pages. Available in PDF, EPUB and Kindle. Book excerpt: BACKGROUND: Many health decisions about screening and treatment for cancers involve uncertainty or tradeoffs between the expected benefits and harms. Patient decision aids have been developed to help health care consumers and their providers identify the available alternatives and choose the one that aligns with their values. It is unclear whether the effectiveness of decision aids for decisions related to cancers differs by people's average risk of cancer or by the content and format of the decision aid. OBJECTIVES: We sought to appraise and synthesize the evidence assessing the effectiveness of decision aids targeting health care consumers who face decisions about cancer screening or prevention, or early cancer treatment (Key Question 1), particularly with regard to decision aid or patient characteristics that might function as effect modifiers. We also reviewed interventions targeting providers for promotion of shared decision making using decision aids (Key Question 2). DATA SOURCES: We searched MEDLINE(r), Embase(r), the Cochrane Central Register of Controlled Trials (CENTRAL), PsycINFO(r), and the Cumulative Index to Nursing and Allied Health Literature (CINAHL(r)) from inception to the end of June 2014. REVIEW METHODS: For Key Question 1, we included randomized controlled trials comparing decision aid interventions among themselves or with a control. We included trials of previously developed decision aids that were delivered at the point of the actual decision. We predefined three population groups of interest based on risk or presence of cancer (average cancer risk, high cancer risk, early cancer). The assessed outcomes pertained to measurements of decisional quality and cognition (e.g., knowledge scores), attributes of the decision-making process (e.g., Decisional Conflict Scale), emotion and quality of life (e.g., decisional regret), and process and system-level attributes. We assessed for effect modification by population group, by the delivery format or content of the decision aid or other attributes, or by methodological characteristics of the studies. For Key Question 2, we included studies of any intervention to promote patient decision aid use, regardless of study design and outcomes assessed. RESULTS: Of the 16,669 screened citations, 87 publications were eligible, corresponding to 83 (68 trials; 25,337 participants) and 5 reports for Key Questions 1 and 2, respectively. Regarding the evolution of the decision aid format and content over time, more recent trials increasingly studied decision aids that were more practical to deliver (e.g., over the Internet or without human mediation) and more often clarified preferences explicitly. Overall, participants using decision aids had higher knowledge scores compared with those not using decision aids (standardized mean difference, 0.23; 95% credible interval [CrI], 0.09 to 0.35; 42 comparison strata with 12,484 participants). Compared with not using decision aids, using decision aids resulted in slightly lower decisional conflict scores (weighted mean difference of -5.3 units [CrI, -8.9 to -1.8] on the 0-100 Decisional Conflict Scale; 28 comparison strata; 7,923 participants). There was no difference in State-Trait Anxiety Inventory scores (weighted mean difference = 0.1; 95% CrI, -1.0 to 0.7 on a 20-80 scale; 16 comparison strata; 2,958 participants). Qualitative synthesis suggested that patients using decision aids are more likely to make informed decisions and have accurate risk perceptions; further, they may make choices that best agree with their values and may be less likely to remain undecided. Because there was insufficient, sparse, or no information about effects of decision aids on patient-provider communication, patient satisfaction with decision-making process, resource use, consultation length, costs, or litigation rates, a quantitative synthesis was not done. There was no evidence for effect modification by population group, by the delivery format or content of the decision aid or other attributes, or by methodological characteristics of the studies. Data on Key Question 2 were very limited. CONCLUSIONS: Cancer-related decision aids have evolved over time, and there is considerable diversity in both format and available evidence. We found strong evidence that cancer-related decision aids increase knowledge without adverse impact on decisional conflict or anxiety. We found moderate- or low-strength evidence that patients using decision aids are more likely to make informed decisions, have accurate risk perceptions, make choices that best agree with their values, and not remain undecided. This review adds to the literature that the effectiveness of cancer-related decision aids does not appear to be modified by specific attributes of decision aid delivery format, content, or other characteristics of their development and implementation. Very limited information was available on other outcomes or on the effectiveness of interventions that target providers to promote shared decision making by means of decision aids.
Book Synopsis Handbook of Health Psychology and Behavioral Medicine by : Jerry M. Suls
Download or read book Handbook of Health Psychology and Behavioral Medicine written by Jerry M. Suls and published by Guilford Press. This book was released on 2011-07-06 with total page 625 pages. Available in PDF, EPUB and Kindle. Book excerpt: What psychological and environmental forces have an impact on health? How does behavior contribute to wellness or illness? This comprehensive volume answers these questions and others with a state-of-the-art overview of theory, research, and practice at the interface of psychology and health. Leading experts from multiple disciplines explore how health and health behaviors are shaped by a wide range of psychological processes and social-environmental factors. The book describes exemplary applications in the prevention and clinical management of today's most pressing health risks and diseases, including coronary heart disease, depression, diabetes, cancer, chronic pain, obesity, sleep disturbances, and smoking. Featuring succinct, accessible chapters on critical concepts and contemporary issues, the Handbook integrates psychological perspectives with cutting-edge work in preventive medicine, epidemiology, public health, genetics, nursing, and the social sciences.
Book Synopsis Benefits and Harms of Prostate-specific Antigen Screening for Prostate Cancer by : Kenneth Lin
Download or read book Benefits and Harms of Prostate-specific Antigen Screening for Prostate Cancer written by Kenneth Lin and published by . This book was released on 2008 with total page pages. Available in PDF, EPUB and Kindle. Book excerpt: BACKGROUND: Prostate cancer is the most common nonskin cancer in men in the United States, and prostate cancer screening has increased in recent years. In 2002, the U.S. Preventive Services Task Force concluded that evidence was insufficient to recommend for or against screening for prostate cancer with prostate-specific antigen (PSA) testing. PURPOSE: To examine new evidence of benefits and harms of screening asymptomatic men for prostate cancer with PSA testing. DATA SOURCES: English-language articles identified in PubMed and the Cochrane Library (search dates, January 2002 to July 2007), reference lists of retrieved articles, and expert suggestions. STUDY SELECTION: Randomized, controlled trials and meta-analyses of PSA screening and cross-sectional and cohort studies of screening harms and of the natural history of screening-detected cancer were selected to answer the following questions: Does screening for prostate cancer with PSA, as a single-threshold test or as a function of multiple tests over time, decrease morbidity or mortality? What are the magnitude and nature of harms associated with prostate cancer screening, other than overtreatment? What is the natural history of PSA-detected, nonpalpable, localized prostate cancer? DATA EXTRACTION: Studies were reviewed, abstracted, and rated for quality by using predefined U.S. Preventive Services Task Force criteria. DATA SYNTHESIS: No good-quality randomized, controlled trials of screening for prostate cancer have been completed. In 1 cross-sectional and 2 prospective cohort studies of fair to good quality, false-positive PSA screening results caused psychological adverse effects for up to 1 year after the test. The natural history of PSA-detected prostate cancer is poorly understood. LIMITATIONS: Few eligible studies were identified. Long-term adverse effects of false-positive PSA screening test results are unknown. CONCLUSION: Prostate-specific antigen screening is associated with psychological harms, and its potential benefits remain uncertain. Prostate cancer is the most common nonskin cancer in U.S. men. An estimated 218,890 men received a new diagnosis of prostate cancer in 2007, and 1 in 6 men will receive a diagnosis in their lifetime. The American Cancer Society estimates that 27,350 men died of prostate cancer in 2006. After peaking in 1991 (29.4 deaths per 100,000 men), the prostate cancer mortality rate has gradually decreased. Although this positive trend may be related to increased screening for prostate cancer, other factors, including new treatment approaches, could also account for some or all of the observed decline in mortality. The serum prostate-specific antigen (PSA) test was approved by the U.S. Food and Drug Administration in 1986, and its use for prostate cancer screening has increased substantially since the mid-1990s. However, PSA testing is not specific to prostate cancer; common conditions, such as benign prostatic hyperplasia and prostatitis, also increase PSA levels. Approximately 1.5 million U.S. men age 40 to 69 years have a PSA level greater than 4.0 ơg/L, a widely used cutoff value for a positive screening result. Refinements designed to improve the PSA test's sensitivity and specificity for prostate cancer include determination of PSA density, PSA velocity, PSA doubling time, and percentage of free PSA. Potential harms from PSA screening include additional medical visits, adverse effects of prostate biopsies, anxiety, and overdiagnosis (the identification of prostate cancer that would never have caused symptoms in the patient's lifetime, leading to unnecessary treatment and associated adverse effects). Much uncertainty surrounds which cases of prostate cancer require treatment and whether earlier detection leads to improvements in duration or quality of life. Two recent systematic reviews of the comparative effectiveness and harms of therapies for localized prostate cancer concluded that no single therapy is superior to all others in all situations. In 2002, the U.S. Preventive Services Task Force (USPSTF) found insufficient evidence to recommend for or against routine screening for prostate cancer. The USPSTF found good evidence that PSA screening can detect early-stage prostate cancer but found mixed and inconclusive evidence that screening and early detection improve health outcomes. Consequently, the USPSTF was unable to determine the balance between benefits and harms of periodic screening for prostate cancer. The analytic framework that guided the previous USPSTF evidence review (Figure) included 8 key questions about benefits and harms of prostate cancer screening and treatment. This evidence update focuses on critical gaps in the evidence that the Task Force identified in the previous review: the lack of good-quality studies linking screening to improved health outcomes; limited information about harms of screening; and a paucity of knowledge about the natural history of PSA-detected, nonpalpable, localized prostate cancer (the most common type of prostate cancer detected today). These evidence gaps produced 3 new key questions for this update: 1. Does screening for prostate cancer with PSA, as a single-threshold test or as a function of multiple tests over time, decrease morbidity or mortality? 2. What are the magnitude and nature of harms associated with prostate cancer screening other than overtreatment? 3. What is the natural history of PSA-detected, nonpalpable, localized prostate cancer?
Book Synopsis Prostate-specific Antigen-based Screening for Prostate Cancer by :
Download or read book Prostate-specific Antigen-based Screening for Prostate Cancer written by and published by . This book was released on 2011 with total page 56 pages. Available in PDF, EPUB and Kindle. Book excerpt: BACKGROUND: In 2008, the U.S. Preventive Services Task Force (USPSTF) concluded that the evidence was insufficient to assess the balance of benefits and harms of screening for prostate cancer in men younger than age 75 years. The USPSTF recommended against screening for prostate cancer in men aged 75 years or older. PURPOSE: To update a previous systematic review performed for the USPSTF and evaluate new evidence on the potential benefits of prostate-specific antigen (PSA)-based screening for prostate cancer. DATA SOURCES: English-language articles identified in PubMed and the Cochrane Library (search dates January 2007 to July 2011), reference lists of retrieved articles, and expert suggestions. STUDY SELECTION: Randomized controlled trials, systematic reviews, and meta-analyses were selected to determine whether PSA-based screening decreases prostate cancer-specific or all-cause mortality. Where available, information on the potential harms of screening for prostate cancer was also extracted from included studies. DATA EXTRACTION: Studies were reviewed, abstracted, and rated for quality, using predefined USPSTF criteria. DATA SYNTHESIS: Five randomized controlled trials (two fair- and three poor-quality) and two meta-analyses evaluating the impact of PSA-based screening on prostate cancer mortality were identified. A report describing results from a single center participating in one of the fair-quality trials was also identified. Of the two highest-quality trials, the U.S. Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial found no statistically significant effect of PSA-based screening on prostate cancer mortality after 10 years (rate ratio [RR], 1.11 [95% CI, 0.83-1.50]). The European Randomized Study of Screening for Prostate Cancer also found no statistically significant effect in all enrolled men (ages 50-74 years) after a median followup of 9 years (RR, 0.85 [95% CI, 0.73-1.00]), but reported a 0.07% absolute risk reduction in a prespecified subgroup of men aged 55 to 69 years (RR, 0.80 [95% CI, 0.65-0.98]). Neither meta-analysis indicated a reduction in prostate cancer mortality with the use of PSA-based screening. When a benefit was found, PSA-based screening resulted in an estimated 48 additional men being treated for each prostate cancer death that was averted. Twelve percent to 13% of screened men had false-positive results after 3 to 4 screening rounds, and clinically important infections, bleeding, or urinary retention occurred after 0.5%-1.0% of prostate biopsies. LIMITATIONS: Evidence was conflicting regarding the effect of screening on prostate cancer mortality in the highest-quality trials; they also represented interim results. We restricted the search on the potential harms of PSA-based screening to information available from randomized efficacy trials. CONCLUSIONS: After about 10 years, PSA-based screening results in the detection of more cases of prostate cancer, but small to no reduction in prostate cancer-specific mortality.
Book Synopsis Fulfilling the Potential of Cancer Prevention and Early Detection by : National Research Council
Download or read book Fulfilling the Potential of Cancer Prevention and Early Detection written by National Research Council and published by National Academies Press. This book was released on 2003-05-07 with total page 564 pages. Available in PDF, EPUB and Kindle. Book excerpt: Cancer ranks second only to heart disease as a leading cause of death in the United States, making it a tremendous burden in years of life lost, patient suffering, and economic costs. Fulfilling the Potential for Cancer Prevention and Early Detection reviews the proof that we can dramatically reduce cancer rates. The National Cancer Policy Board, part of the Institute of Medicine, outlines a national strategy to realize the promise of cancer prevention and early detection, including specific and wide-ranging recommendations. Offering a wealth of information and directly addressing major controversies, the book includes: A detailed look at how significantly cancer could be reduced through lifestyle changes, evaluating approaches used to alter eating, smoking, and exercise habits. An analysis of the intuitive notion that screening for cancer leads to improved health outcomes, including a discussion of screening methods, potential risks, and current recommendations. An examination of cancer prevention and control opportunities in primary health care delivery settings, including a review of interventions aimed at improving provider performance. Reviews of professional education and training programs, research trends and opportunities, and federal programs that support cancer prevention and early detection. This in-depth volume will be of interest to policy analysts, cancer and public health specialists, health care administrators and providers, researchers, insurers, medical journalists, and patient advocates.
Book Synopsis Clinical Oncology by : Martin D. Abeloff
Download or read book Clinical Oncology written by Martin D. Abeloff and published by . This book was released on 2000 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: A must-have reference, this new edition provides practical information on treatment guidelines, details of diagnosis and therapy, and personal recommendations on patient management from experts in the field. Consistently formatted chapters allow for a user-friendly presentation for quick access of key information by the practicing clinician. Completely updated, this new edition includes all of the latest developments in treatment strategies of medical, surgical and radiation oncologists.
Book Synopsis Care Without Coverage by : Institute of Medicine
Download or read book Care Without Coverage written by Institute of Medicine and published by National Academies Press. This book was released on 2002-06-20 with total page 213 pages. Available in PDF, EPUB and Kindle. Book excerpt: Many Americans believe that people who lack health insurance somehow get the care they really need. Care Without Coverage examines the real consequences for adults who lack health insurance. The study presents findings in the areas of prevention and screening, cancer, chronic illness, hospital-based care, and general health status. The committee looked at the consequences of being uninsured for people suffering from cancer, diabetes, HIV infection and AIDS, heart and kidney disease, mental illness, traumatic injuries, and heart attacks. It focused on the roughly 30 million-one in seven-working-age Americans without health insurance. This group does not include the population over 65 that is covered by Medicare or the nearly 10 million children who are uninsured in this country. The main findings of the report are that working-age Americans without health insurance are more likely to receive too little medical care and receive it too late; be sicker and die sooner; and receive poorer care when they are in the hospital, even for acute situations like a motor vehicle crash.
Book Synopsis Helping people share decision making by : Debra de Silva
Download or read book Helping people share decision making written by Debra de Silva and published by The Health Foundation. This book was released on 2012 with total page 78 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Health Promotion written by Marilyn Frenn and published by F.A. Davis. This book was released on 2021-01-05 with total page 803 pages. Available in PDF, EPUB and Kindle. Book excerpt: Take an evidence-based approach to health promotion across the lifespan and clinical specialties. Written for NPs and advanced practitioners, this text provides coaching in how to read, evaluate, and apply the best evidence to health promotion plans for individuals and their families to help them prevent or manage chronic and acute diseases and disorders. Step-by-step, a who’s who of educators, researchers, and practitioners explore the models and skills you need to help your patients, including those with multiple co-morbidities, while evaluating medical evidence that changes rapidly, or may be unclear. You’ll also be prepared for the health promotion questions on certification exams.
Book Synopsis International Handbook of Health Literacy by : Ullrich Bauer
Download or read book International Handbook of Health Literacy written by Ullrich Bauer and published by Policy Press. This book was released on 2019-07-31 with total page 768 pages. Available in PDF, EPUB and Kindle. Book excerpt: Available Open Access under CC-BY-NC licence. Health literacy addresses a range of social dimensions of health, including knowledge, navigation and communication, as well as individual and organizational skills for accessing, understanding, evaluating and using information. Particularly over the past decade, health literacy has globally become a major public health concern as an asset for promoting health, wellbeing and sustainable development. This comprehensive handbook provides an invaluable overview of current international thinking about health literacy, highlighting cutting edge research, policy and practice in the field. With a diverse team of contributors, the book addresses health literacy across the life-span and offers insights from different populations and settings. Providing a wide range of major findings, the book outlines current discourse in the field and examines necessary future dialogues and new perspectives.
Book Synopsis Illness Narratives in Practice: Potentials and Challenges of Using Narratives in Health-Related Contexts by : Gabriele Lucius-Hoene
Download or read book Illness Narratives in Practice: Potentials and Challenges of Using Narratives in Health-Related Contexts written by Gabriele Lucius-Hoene and published by . This book was released on 2018 with total page 385 pages. Available in PDF, EPUB and Kindle. Book excerpt: Comprehensive overview of illness narratives in practice, divided into eight distinct parts. The clear layout allows the readers to focus on the area essential to them and get a comprehensive overview and reflective stance of narratives in that field.
Book Synopsis Transgender Medicine by : Leonid Poretsky
Download or read book Transgender Medicine written by Leonid Poretsky and published by Springer. This book was released on 2019-02-22 with total page 481 pages. Available in PDF, EPUB and Kindle. Book excerpt: Although transgender persons have been present in various societies throughout human history, it is only during the last several years that they have become widely acknowledged in our society and their right to quality medical care has been established. In the United States, endocrinologists have been providing hormonal therapy for transgender individuals for decades; however, until recently, there has been only limited literature on this subject, and non-endocrine aspects of medical care for transgender individual have not been well addressed in the endocrine literature. The goal of this volume is not only to address the latest in hormonal therapy for transgender individuals (including pediatric and geriatric age groups), but also to familiarize the reader with other aspects of transgender care, including primary and surgical care, fertility preservation, and the management of HIV infection. In addition to medical issues, psychological, social, ethical and legal issues pertinent to transgender individuals add to the complexities of successful treatment of these patients. A final chapter includes extensive additional resources for both transgender patients and providers. Thus, an endocrinologist providing care to a transgender person will be able to use this single resource to address most of the patient’s needs. While Transgender Medicine is intended primarily for endocrinologists, this book will be also useful to primary care physicians, surgeons providing gender-confirming procedures, mental health professionals participating in the care of transgender persons, and medical residents and students.
